Report cover image

Biologic Therapeutic Drugs: Technologies and Global Markets

Publisher BCC Research
Published May 14, 2025
Length 170 Pages
SKU # WA20050975

Description

Report Scope

This report provides an overview of the global biologic therapeutic drug market and analyzes market trends. It includes global revenue ($U.S. millions) for base year data for 2023 and estimated data for 2024. The forecast period is 2024 through 2029. The market is segmented based on product type, application, source and region. By product, the market is segmented into monoclonal antibodies, vaccines, peptide hormones, cell and gene therapies and others. By source, it is segmented into mammalian, microbial and others. By application, the market is segmented into oncology, autoimmune diseases, infectious diseases and others. The regions covered in this study are North America, Europe, Asia-Pacific, Middle East and Africa, and South America, focusing on the major countries in these regions. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes corporate environmental, social and governance (ESG) developments and discusses emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking and share of key players in the global biologic therapeutic drug market. It also has a section dedicated to company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.

Report Includes
  • 49 data tables and 58 additional tables
  • An overview of the current and future global markets for biologic therapeutic drugs and technologies
  • An analysis of the global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
  • Estimates of the size and revenue prospects of the global market, along with a market share analysis by product type, application, source and region
  • Facts and figures pertaining to market dynamics, technological advances, regulations, and the impact of macroeconomic factors
  • Evaluation of the ongoing clinical trials and R&D activity for biologics production
  • A look at the key drugs on the market and recent approvals, sales statistics and past performance of the top-selling biologics
  • An analysis of patents, emerging trends and other developments in the industry
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Company profiles of major players within the industry, including Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Pfizer Inc., and Bristol-Myers Squibb Co.


Companies Mentioned

Abbvie Inc.
Amgen Inc.
Astrazeneca
Bristol-myers Squibb Co.
Eli Lilly And Co.
F. Hoffmann-la Roche Ltd.
Gilead Sciences Inc.
Gsk Plc.
Johnson & Johnson Services Inc.
Merck & Co. Inc.
Novartis Ag
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi

Table of Contents

170 Pages
Chapter 1 Executive Summary
Market Outlook
Scope Of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Technological Advances
Conclusion
Chapter 2 Market Overview
Overview
Biologic And Synthetic Drug Comparison
Biologic Manufacturing
Biopharmaceutical Manufacturing Process
Macroeconomic Factors Analysis
Porter’s Five Forces Analysis
Supply Chain Analysis
Cell And Gene Therapy Supply Chain
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Demand For Biologics
Rising Investments In Biopharmaceuticals
Product Development Collaborations And Agreements
Transition Toward Personalized Medicines
Rising Aging Population And The Growing Prevalence Of Chronic Diseases
Market Restraints
Emergence Of Biosimilars
Complex Manufacturing, Lack Of Skilled Professionals And High Production Costs
Market Opportunities
Rising Demand For Biopharmaceuticals In Emerging Countries
Technological Innovations In Biologics
Chapter 4 Regulatory Landscape
U.S. Approval Process
European Union Approval Process
Asia-pacific Approval Process
Chapter 5 Emerging Technologies And Developments
Emerging Technologies
Advances In Monoclonal Antibodies
Antibody-drug Conjugates
Bispecific Antibodies
Nanobodies
Single-chain Variable Fragments Antibodies
Antibody Mimetics
Antibody Fusion Proteins
Advances In Vaccines
Advances In Cell And Gene Therapies
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis By Product Type
Monoclonal Antibodies
Vaccines
Peptide Hormones
Cell And Gene Therapy
Others
Market Analysis By Source Type
Mammalian
Microbial
Others
Market Analysis By Application
Oncology
Autoimmune Disease
Infectious Diseases
Others
Geographic Breakdown
Market Analysis By Region
North America
Europe
Asia-pacific
Rest Of The World
Chapter 7 Competitive Intelligence
Overview
Highest Selling Biologic Therapeutic Drugs
Market Share Analysis
Monoclonal Antibodies
Vaccines
Peptide Hormones
Cell And Gene Therapy
Strategic Initiatives
Agreements, Collaborations And Partnerships
Acquisitions
Other Strategies
Chapter 8 Sustainability In Biologics Therapeutic Drug Market: An Esg Perspective
Introduction To Esg
Sustainability Trends And Initiatives
Environmental
Social And Governance Initiatives
Esg Risk Ratings
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Emerging Start-ups/Market Disruptors
Sources
Abbreviations
Company Profiles
Abbvie Inc.
Amgen Inc.
Astrazeneca
Bristol-myers Squibb Co.
Eli Lilly And Co.
F. Hoffmann-la Roche Ltd.
Gilead Sciences Inc.
Gsk Plc.
Johnson & Johnson Services Inc.
Merck & Co. Inc.
Novartis Ag
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us